Apellis Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

533,909

Value ($000)

13,412

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	13,412	0.0%	533,909	12/31/2025
2025 Q3	11/14/2025	7,103	0.0%	313,884	9/30/2025
2025 Q2	8/14/2025	5,690	0.0%	328,726	6/30/2025
2025 Q1	5/14/2025	645	0.0%	29,505	3/31/2025
2024 Q4	2/14/2025	837	0.0%	26,217	12/31/2024
2024 Q3	11/14/2024	4,954	0.0%	171,792	9/30/2024
2024 Q2	8/15/2024	18,373	0.0%	478,963	6/30/2024
2024 Q1	5/7/2024	14,358	0.0%	244,261	3/31/2024
2023 Q4	2/14/2024	22,916	0.0%	382,832	12/31/2023
2023 Q3	11/14/2023	14,181	0.0%	372,785	9/30/2023
2023 Q2	8/11/2023	28,779	0.0%	315,910	6/30/2023
2023 Q1	5/16/2023	5,395	0.0%	81,796	3/31/2023
2022 Q4	2/14/2023	1,641	0.0%	31,732	12/31/2022
2022 Q3	11/14/2022	3,952	0.0%	57,860	9/30/2022
2022 Q2	8/15/2022	2,432	0.0%	53,780	6/30/2022
2022 Q1	5/16/2022	3,843	0.0%	75,635	3/31/2022
2021 Q4	2/14/2022	3,250	0.0%	68,749	12/31/2021
2021 Q3	11/15/2021	3,606	0.0%	109,410	9/30/2021
2021 Q2	8/11/2021	1,818	0.0%	28,769	6/30/2021
2021 Q1	5/17/2021	1,112	0.0%	25,923	3/31/2021
2020 Q4	2/16/2021	786	0.0%	13,740	12/31/2020
2020 Q3	11/16/2020	1,293	0.0%	42,843	9/30/2020
2020 Q2	8/14/2020	2,896	0.0%	88,661	6/30/2020
2020 Q1	5/15/2020	3,370	0.0%	125,794	3/31/2020
2019 Q4	2/14/2020	4,021	0.0%	131,332	12/31/2019